Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol.

ABSTRACT:

Introduction

Obstructive lung diseases (OLDs) such as asthma and chronic obstructive pulmonary disease are major global sources of morbidity and mortality. Current treatments broadly include bronchodilators such as beta agonists/antimuscarinics and anti-inflammatory agents such as steroids. Despite therapy patients still experience exacerbations of their diseases and overall decline over time. Nebulised furosemide may have a novel use in the treatment of OLD. Multiple small studies have shown improvement in pulmonary function as well as dyspnoea. This systematic review will aim to summarise and analyse the existing literature on nebulised furosemide use in OLD to guide treatment and future studies.

Methods and analysis

We will identify all experimental studies using nebulise

SUBMITTER: Veldhoen R 

PROVIDER: S-EPMC10668269 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature